More information: Charlie A. Hamm et al, Oncological Safety of MRI-Informed Biopsy Decision-Making in Men With Suspected Prostate Cancer, JAMA Oncology (2024). DOI: 10.1001/jamaoncol.2024.5497 ...
MRI should be considered an adjunct to, and not a replacement for, biopsies for men on active surveillance for prostate cancer. MRI does not consistently rule out the presence of Gleason grade ...
This can "significantly cut" the number of "expensive and unnecessary MRI scans" and invasive prostate biopsies, he added. Oliver Kemp, chief executive of Prostate Cancer Research, called Sunak's ...
Prostate zonal anatomy is best demonstrated with MRI. On T2-weighted sequences, the normal prostate can be divided into the peripheral zone, which shows high signal intensity owing to its high ...
Serum prostate-specific antigen was3.4 ng/ml. Bone scintigraphy and baseline CT were reportedlynegative. Investigations: Physical examination, laboratory evaluation,endorectal MRI of the prostate ...
Association of PSMA PET results at biochemical recurrence (BCR) with metastasis free survival (MFS) by conventional imaging (CI) in patients with locally advanced or high-risk localized prostate ...
Clinical protocols to monitor efficacy of [177Lu]Lu-PSMA radiopharmaceutical therapy in metastatic castration-resistant prostate cancer. This is an ASCO Meeting Abstract from the 2025 ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback